Next, we wanted to assess the sensitivity of VCAM-1–targeted MPIO (VCAM-MPIO) in conjunction with T2*-weighted MRI for detection of the tumor-brain interface compared with conventional MRI, and further extend this analysis to a xenograft model of medulloblastoma to assess its broader applicability. This evidence concerns the gene VCAM1 and medulloblastoma.